Alfa Aesar now offers full suite of chemical services for pharmaceuticals

Published: 21-Mar-2011
Manufacturing Research & Development

New brochure outlines services from lab to bulk API production

Alfa Aesar, a Johnson Matthey company, has published a new non-GMP and GMP services brochure that outlines services from lab to bulk API production provided by Alfa Aesar and Johnson Matthey Pharmaceutical Services and Materials.

The eight-page brochure details the chemical products and services offered by Alfa Aesar and Johnson Matthey Pharmaceutical Services and Materials to cover the full scope of the drug development pipeline.

The pharmaceutical portfolio includes a catalogue of more than 33,000 building blocks and screening compounds, cGMP compliant commercial manufacturing, Full Time Equivalent (FTE) services, and a full suite of services in between.

Alfa Aesar and Johnson Matthey Pharmaceutical Services and Materials offer full regulatory and cGMP compliance in all aspects, including chemical development, catalytic screening, lab scale production and more.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

Read more
New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Thermo Fisher Scientific opens manufacturing centre of excellence site in North Carolina

New manufacturing facility in Mebane (NC, US) site to significantly increase laboratory pipette production in the US
Sustainability

Thermo Fisher launches new Heratherm Environmental Chamber for high-performance stability testing

The sustainable, precision-controlled chamber meets 21 CFR Part 11 and ICH guidelines
Manufacturing

Thermo Fisher teams up with Xcellbio to further cell and gene therapy research

The pair will focus on Treg and TIL research, with the intention of developing therapeutics for autoimmune and solid tumour diseases
Manufacturing

Thermo Fisher's Accelerator CDMO and CRO solutions can slash drug development times by 3 years, study finds

The centralised solution can streamline the drug development process, facilitating the rapid commercialisation of new therapeutics
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating therapeutic manufacturing with smart and sustainable technologies

In this article, John Puglia, Senior Director of Research and Development, Single-Use Technologies, at Thermo Fisher Scientific, explores how innovative technologies are revolutionising biomanufacturing for a smarter, more sustainable future
Manufacturing

Ethris and Thermo Fisher Scientific to provide mRNA technology to biopharma market

Ethris will combine its mRNA technology platforms with Thermo Fisher's GMP manufacturing capacity to serve the biopharmaceutical market
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Unlocking the secrets of cells: the revolutionary power of spatial biology

Spatial biology is the study of biomolecules and cells within their native tissue microenvironment. This approach has enabled scientists to develop a better understanding of cell interactions in their natural locations
Subscribe now